ArticleOncotarget2017
Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.
Xuemei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleOncotarget2017
Xuemei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.